145 related articles for article (PubMed ID: 36623339)
1. Facing points of view: Representations on adjuvant endocrine therapy of premenopausal patients after breast cancer and their healthcare providers in France. The FOR-AD study.
Roche N; Le Provost JB; Borinelli-Franzoi MA; Boinon D; Martin E; Menvielle G; Dumas A; Rivera S; Conversano A; Matias M; Viansone A; Di Meglio A; Delaloge S; Vaz-Duarte-Luis IM; Pistilli B; Fasse L
Eur J Oncol Nurs; 2023 Feb; 62():102259. PubMed ID: 36623339
[TBL] [Abstract][Full Text] [Related]
2. Both "Vitamin L for Life" and "One Milligram of Satan": A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer.
Toivonen KI; Oberoi D; King-Shier K; Piedalue KL; Rash JA; Carlson LE; Campbell TS
Curr Oncol; 2021 Jul; 28(4):2496-2515. PubMed ID: 34287250
[TBL] [Abstract][Full Text] [Related]
3. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
4. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
Goel S; Sharma R; Hamilton A; Beith J
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004562. PubMed ID: 19821328
[TBL] [Abstract][Full Text] [Related]
5. Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study
.
Bourmaud A; Rousset V; Regnier-Denois V; Collard O; Jacquin JP; Merrouche Y; Lapoirie J; Tinquaut F; Lataillade L; Chauvin F
Oncol Nurs Forum; 2016 May; 43(3):E94-E103. PubMed ID: 27105205
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
Balazard F; Bertaut A; Bordet É; Mulard S; Blanc J; Briot N; Paux G; Dhaini Merimeche A; Rigal O; Coutant C; Fournier M; Jouannaud C; Soulie P; Lerebours F; Cottu PH; Tredan O; Vanlemmens L; Levy C; Mouret-Reynier MA; Campone M; Brady KJS; Sasane M; Rice M; Coulouvrat C; Martin AL; Jacquet A; Vaz-Luis I; Herold C; Pistilli B
J Natl Cancer Inst; 2023 Sep; 115(9):1099-1108. PubMed ID: 37434306
[TBL] [Abstract][Full Text] [Related]
7. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
[TBL] [Abstract][Full Text] [Related]
8. Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
Hurtado-de-Mendoza A; Cabling ML; Lobo T; Dash C; Sheppard VB
Clin Breast Cancer; 2016 Aug; 16(4):247-255.e3. PubMed ID: 27133733
[TBL] [Abstract][Full Text] [Related]
9. Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer.
Lambert LK; Balneaves LG; Howard AF; Chia SLK; Gotay CC
Curr Oncol; 2021 Apr; 28(2):1472-1482. PubMed ID: 33918560
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
Cavazza M; Banks H; Ercolanoni M; Cukaj G; Bianchi G; Capri G; Longo F
Breast Cancer Res Treat; 2020 Aug; 183(1):189-199. PubMed ID: 32591986
[TBL] [Abstract][Full Text] [Related]
11. Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and Literature.
Tancredi R; Furlanetto J; Loibl S
Oncologist; 2018 Aug; 23(8):974-981. PubMed ID: 29934412
[TBL] [Abstract][Full Text] [Related]
12. Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.
Davidson B; Vogel V; Wickerham L
J Support Oncol; 2007 Mar; 5(3):139-43. PubMed ID: 17410813
[TBL] [Abstract][Full Text] [Related]
13. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
Sharma R; Hamilton A; Beith J
Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
[TBL] [Abstract][Full Text] [Related]
14. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.
Kroenke CH; Hershman DL; Gomez SL; Adams SR; Eldridge EH; Kwan ML; Ergas IJ; Kubo A; Kushi LH
Breast Cancer Res Treat; 2018 Aug; 170(3):623-631. PubMed ID: 29671113
[TBL] [Abstract][Full Text] [Related]
15. Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study.
Hagen KB; Aas T; Kvaløy JT; Søiland H; Lind R
Breast; 2019 Apr; 44():52-58. PubMed ID: 30641300
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
Blanchette PS; Lam M; Richard L; Allen B; Shariff SZ; Vandenberg T; Pritchard KI; Chan KKW; Louie AV; Desautels D; Raphael J; Earle CC
Breast Cancer Res Treat; 2020 Jan; 179(1):217-227. PubMed ID: 31571072
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
[TBL] [Abstract][Full Text] [Related]
19. Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
Wassermann J; Gelber SI; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Come SE; Meyer ME; Partridge AH
Cancer; 2019 Sep; 125(18):3266-3274. PubMed ID: 31120571
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant endocrine therapy in premenopausal breast cancer: a initial dedicated counseling: can it be useful for better adherence?].
Lesur A; Dalenc F; Beguignot M
Bull Cancer; 2019 Dec; 106(12S1):S28-S36. PubMed ID: 32008735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
